Skip Over Navigation Links

Interest Groups of the PGRN, 2003-2005

as of December 11, 2002

Resource & Expertise Groups

Haplotyping, Genotyping, Comparative Genomics

Leaders: Anna DiRienzo, Ph.D., University of Chicago
William Evans, Pharm.D., St. Jude Children’s Research Hospital   

Population Genetics, Study Design, Statistics

Leaders: Michael Province, Ph.D., Washington University
Nicholas Schork, Ph.D., University of California, San Diego

Tissue Resources, Study Populations

Leaders: Mark Watson, Ph.D., Washington University
Catherine Schaefer, Ph.D., Kaiser Permanente

Phenotyping Technologies/Pharmacokinetics

Leaders: Richard Weinshilboum, M.D., Mayo Foundation
Erin Schuetz, Ph.D., St. Jude Children’s Research Hospital
Dawood Darber, M.D., Vanderbilt University
Richard Kim, M.D., Vanderbilt University



Disease Focus Groups

Cancer

Leaders: Howard McLeod, Pharm. D., Washington University
Deanna Kroetz, Ph.D., University of California, San Francisco

Cardiovascular-Pulmonary Signaling Systems

Leaders: Ronald Krauss, M.D., Lawrence Berkeley National Laboratory
Stephen Liggett, M.D., University of Cincinnati
Daniel O’Connor, M.D., University of California, San Diego

Adverse Drug Reactions

Leaders: Kathleen Giacomini, Ph.D., University of California, San Francisco
Dan Roden, M.D., Vanderbilt University



Interest Groups Coordination

Leaders: Mary Relling, Pharm.D., St. Jude Children’s Research Hospital
Jerome Rotter, M.D., Cedars-Sinai Health System

This page last reviewed on November 14, 2014